Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Technology Reporter.
Press releases published on August 25, 2025
Humanoid Global Announces CEO Transition
GlobeNewswire
·
August 25, 2025
Vancouver, BC, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF) announced today changes to its management. Shahab Samimi will serve as the Chief Executive Officer of the …
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025
GlobeNewswire
·
August 25, 2025
Positive Results from MAPLE-HCM to be Shared in Hot Line Presentation Late Breaking Clinical Science Session to Present Incidence and Impact of Atrial Fibrillation Across Three Clinical Trials of Aficamten in Obstructive Hypertrophic Cardiomyopathy Company …
Propanc Biopharma Provides Shareholder Update
GlobeNewswire
·
August 25, 2025
MELBOURNE, Australia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today …
Synaptics To Participate at Upcoming Investor Conferences on Thursday, August 28, 2025 and Thursday, September 4, 2025
GlobeNewswire
·
August 25, 2025
SAN JOSE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA) today announced its participation in upcoming investor conferences. Ken Rizvi, CFO, will participate at the Deutsche Bank’s Technology Conference on Thursday, August …
Incyclix Bio Secures $11.25 Million Series B Extension to Advance the Phase 1/2 Clinical Trial of INX-315 in Patients with CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer or CCNE1-Amplified Solid Tumors
GlobeNewswire
·
August 25, 2025
RESEARCH TRIANGLE PARK, N.C., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Incyclix Bio, LLC, a next-generation cell cycle control company developing INX-315, a novel, potent and selective CDK2 inhibitor for the treatment of advanced and resistant cancer, today …
Major Drilling to Release Results for its First Quarter on September 8, 2025
GlobeNewswire
·
August 25, 2025
MONCTON, New Brunswick, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Major Drilling Group International Inc. (TSX: MDI) (the “Company”) will release its first quarter results, ended July 31, 2025, on Monday, September 8, 2025 after the markets have closed. Webcast/ …
Climb Bio to Present at Upcoming September 2025 Investor Conferences
GlobeNewswire
·
August 25, 2025
WELLESLEY HILLS, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that members of its executive team will participate in …
iBio Announces Closing of $50 Million Public Offering
GlobeNewswire
·
August 25, 2025
Total gross proceeds of $100 million if all Series G warrants and Series H warrants are exercised for cash Financing was led by Balyasny Asset Management and included participation from Cormorant Asset Management, Adage Capital Partners LP, Ally Bridge …
New Evidence Published Supporting Use of DecisionDx®-SCC Test in Guiding and Improving Treatment Pathway Decisions in NCCN High-Risk Cutaneous Squamous Cell Carcinoma
GlobeNewswire
·
August 25, 2025
New validation study shows DecisionDx-SCC significantly outperforms current staging systems in predicting risk of local recurrence and metastasis for NCCN high-risk patients Clinician survey confirms test results align with treatment decision-making …
I-Mab Announces the Appointment of Seasoned Biotech Executives to the Board of Directors and the Scientific Advisory Board, and the Formation of a Research and Development Committee
GlobeNewswire
·
August 25, 2025
Dr. Robert Lenz, Ms. Xin Liu and Dr. Sean Cao appointed to the Board of Directors Research and Development Committee established to accelerate innovation and long-term growth Dr. Ken Takeshita appointed to the Scientific Advisory Board ROCKVILLE, Md., Aug. …
Jade Biosciences to Participate in Upcoming Conferences
GlobeNewswire
·
August 25, 2025
SAN FRANCISCO and VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”), (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced its …
Sionna Therapeutics Announces First Subjects Dosed in Phase 1 Trial Evaluating NBD1 Stabilizer, SION-451, in Proprietary Dual Combinations in Development for the Treatment of Cystic Fibrosis
GlobeNewswire
·
August 25, 2025
WALTHAM, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that …
Apollo Expands Project Team; Receives Drill Permit for Calico Silver Project
GlobeNewswire
·
August 25, 2025
VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Apollo Silver Corp. (“Apollo” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to announce a number of positive developments at its Calico Silver Project (“Calico” or the …
Biogen and Stoke Therapeutics Announce Presentations of Clinical Data from Studies of Zorevunersen for the Potential Treatment of Dravet Syndrome at the 36th International Epilepsy Congress
GlobeNewswire
·
August 25, 2025
– 3-year data from open-label extension (OLE) studies demonstrate the potential for disease modification with durable seizure reductions and improvements in cognition and behavior on top of standard anti-seizure medicines – – Substantial improvement in …
Erdene Provides Update on Share Consolidation
GlobeNewswire
·
August 25, 2025
HALIFAX, Nova Scotia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Erdene Resource Development Corp. (TSX: ERD; MSE: ERDN; OTCQB: ERDCF) ("Erdene" or the "Company") is pleased to provide an update on the proposed consolidation (the "Consolidation") of Company's …
Golf Superstore Uses Descartes Sellercloud™ to Unify Omnichannel Operations
GlobeNewswire
·
August 25, 2025
ATLANTA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Chattanooga-based Golf Superstore is using Descartes Sellercloud™ integrated …
NorthWest Upsizes Flow Through Financing to $4.1 Million and Closes Final Tranche
GlobeNewswire
·
August 25, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- NorthWest Copper Corp. (“NorthWest” or “the Company”) (TSX-V: NWST) is pleased to announce it has upsized a second …
Bybit Releases Crypto Insights Report, Highlighting Key Technical Levels and Institutional Trends in Ethereum (ETH)
Chainwire
·
August 25, 2025
Dubai, UAE, August 25th, 2025, Chainwire Bybit, the world’s second-largest cryptocurrency exchange by trading volume, released its latest Crypto Insights Report on Ethereum (ETH), outlining the key levels, catalysts, and institutional trends shaping the …
Crafting Seamless Notifications: How EngageLab’s Chrome Extension WebPush Is Transforming User Engagement and Extension Efficiency
GlobeNewswire
·
August 25, 2025
SINGAPORE, Aug. 25, 2025 (GLOBE NEWSWIRE) -- EngageLab launches industry-leading WebPush support for Chrome Extensions, empowering developers and businesses to reach users with real-time, high-impact notifications—no extra permissions, no missed …
Server PSU Supplier Linklieo Expands Global CRPS and Common Redundant Power Solutions
GlobeNewswire
·
August 25, 2025
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Linklieo, a leading server power supply supplier, today announced the expansion of its advanced server PSU, server power supply, and CRPS power supply product lines. Known for delivering dependable and high- …